Scleroderma - Resources

(Page 2)

Highlights	Prognosis	Treatment for Lung Complications
Introduction	Treatment	Treatment for Gastrointestinal Problems
Risk Factors	Medications	Resources
Symptoms and Complications	Other Treatments	References
Causes	Treatment for Raynaud's Phenomenon	References
Diagnosis	Treatment for Skin Thickening

Shoenfeld Y, Katz U. IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients. Autoimmunity. 2005 Mar;38(2):123-37.

Steen VD. Pregnancy in scleroderma. Rheum Dis Clin North Am. 2007;33:345-358.

Tashkin DP, Elashoff R, Clements PJ, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006; 354(25):2655-66.

Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum. 2007;57:1089-1097.

Tyndall A, Furst DE. Adult stem cell treatment of scleroderma. Curr Opin Rheumatol. 2007;19:604-610.

Varga J, Denton C. Systemic Sclerosis and the Scleroderma Spectrum Disorders. In: Firestein: Kelley's Textbook of Rheumatology. 8^th ed. Philadelphia, Pa: Saunders, 2008. chap 77.

Wigley FM. Scleroderma (Systemic Sclerosis). In: Goldman L, Ausiello D. Goldman: Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders, 2008. pp. 2032-2041.

Page: <<Prev 1 | 2

Review Date: 01/04/2011
Reviewed By: Harvey Simon, MD, Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org).